SEC Filing Summary
2026-09-18SEC Filing 4 (0001193125-26-395837)
Roberto Wandenkolk Vieira, President of Oncology at CORCEPT THERAPEUTICS INC, reported a sale of 296 shares of Common Stock on September 16, 2026, at a price of $100.82 per share. This transaction was executed under a 10b5-1 plan adopted prior to his appointment as an officer. Following the sale, Vieira owns 3946 shares. The reported shares include unvested restricted stock awards granted on various dates in 2025 and 2026, which are subject to a one-year vesting period.